LWCFA
TSVT

Loring Wolcott & Coolidge Fiduciary Advisors’s 2seventy bio TSVT Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-123
Closed – – 603
2022
Q3 		$0 Hold
123
– – ﹤0.01% 638
2022
Q2 		$0 Hold
123
– – ﹤0.01% 683
2022
Q1 		$1K Hold
123
– – ﹤0.01% 629
2021
Q4 		$3K Buy
+123
New +$3.84K ﹤0.01% 686

Other funds holding TSVT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's TSVT Position: Q4 2022 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of 2seventy bio (TSVT) in Q4 2022, closing a stake of 123 shares.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in TSVT in Q4 2021 and held it in 4 quarters. The position peaked at $3K in Q4 2021. 142 funds tracked by Wall St. Rank hold TSVT as of Q4 2022.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining 2seventy bio position as of Q4 2022 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 123 2seventy bio shares in Q4 2022.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in 2seventy bio in Q4 2021 and held it in 4 quarters.
  • Loring Wolcott & Coolidge Fiduciary Advisors's 2seventy bio position peaked at $3K in Q4 2021.
  • 142 funds tracked by Wall St. Rank held 2seventy bio as of Q4 2022.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.